38211 Tumor cell deplete of harvst
Also known as: Tumor cell depletion, Leukemic cell depletion
Tumor cell depletion of harvested stem cells, performed to eliminate residual cancer cells from harvested autologous stem cell collections.
In Plain Language
Removing cancer cells from stem cells; Purging harvested cells
Clinical Context
Used in autologous stem cell transplantation to reduce disease relapse by removing contaminating malignant cells from the graft.
RVU Breakdown
| Work RVU | 1.38 |
| Total RVU | 1.38 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
As a surgical CPT code, proper documentation must include the operative report detailing the procedure performed, patient positioning, approach, findings, and any complications. Ensure the diagnosis code (ICD-10) supports medical necessity for the procedure.
How This Code Compares
With a work RVU of 1.38, this code ranks in the 8th percentile among Surgery codes — 5.8x below the median (8.00). The highest wRVU in this category is 106.19.
Specialties
Frequently Asked Questions
What is CPT code 38211?
CPT 38211 (Tumor cell deplete of harvst) is a Surgery code. Tumor cell depletion of harvested stem cells, performed to eliminate residual cancer cells from harvested autologous stem cell collections.
What is the wRVU value for CPT 38211?
The work RVU for CPT 38211 is 1.38. This code is primarily used by Hematology/Oncology, Transplant Medicine.
When is CPT 38211 used?
Used in autologous stem cell transplantation to reduce disease relapse by removing contaminating malignant cells from the graft.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.